Narrow-moat Quest Diagnostics DGX delivered second-quarter results that slightly exceeded our expectations on the top line, but that was offset by earnings that fell slightly short of our full-year ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND (WJW) — In an effort to make COVID ...

Advances in drug treatments for Alzheimer’s disease have opened doors for diagnostics, and Quest is the latest to walk through. The clinical testing giant has put forward a blood test designed to help ...